BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7508535)

  • 1. Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs.
    Del Bino G; Li X; Traganos F; Darzynkiewicz Z
    Leukemia; 1994 Feb; 8(2):281-8. PubMed ID: 7508535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents.
    Gorczyca W; Gong J; Ardelt B; Traganos F; Darzynkiewicz Z
    Cancer Res; 1993 Jul; 53(13):3186-92. PubMed ID: 8319228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of apoptosis by 5-azacytidine: drug concentration-dependent differences in cell cycle specificity.
    Murakami T; Li X; Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
    Cancer Res; 1995 Jul; 55(14):3093-8. PubMed ID: 7541710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle-related expression of p120 nucleolar antigen in normal human lymphocytes and in cells of HL-60 and MOLT-4 leukemic lines: effects of methotrexate, camptothecin, and teniposide.
    Gorczyca W; Bruno S; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1992 Jun; 52(12):3491-4. PubMed ID: 1596908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cell differentiation potentiates apoptosis triggered by prior exposure to DNA-damaging drugs.
    Bhatia U; Traganos F; Darzynkiewicz Z
    Cell Growth Differ; 1995 Aug; 6(8):937-44. PubMed ID: 8547222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different patterns of apoptosis of HL-60 cells induced by cycloheximide and camptothecin.
    Gong J; Li X; Darzynkiewicz Z
    J Cell Physiol; 1993 Nov; 157(2):263-70. PubMed ID: 8227159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
    Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
    Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z
    Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of drug-induced apoptosis in human leukemic cell line (HL-60)].
    Hara S; Tagawa Y; Ayabe H; Darzynkiwicz Z
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():393-9. PubMed ID: 9589041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
    Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells.
    Vondrácek J; Sheard MA; Krejcí P; Minksová K; Hofmanová J; Kozubík A
    J Leukoc Biol; 2001 May; 69(5):794-802. PubMed ID: 11358989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
    Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
    Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis may be either suppressed or enhanced with strategic combinations of antineoplastic drugs or anti-IgM.
    Lin CK; Nguyen TT; Morgan TL; Mei RL; Kaptein JS; Kalunta CI; Yen CF; Park E; Zou HY; Lad PM
    Exp Cell Res; 1998 Oct; 244(1):1-13. PubMed ID: 9770343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
    Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis in antitumor strategies: modulation of cell cycle or differentiation.
    Darzynkiewicz Z
    J Cell Biochem; 1995 Jun; 58(2):151-9. PubMed ID: 7673323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells.
    Takase K; Sawai M; Yamamoto K; Yata J; Takasaki Y; Teraoka H; Tsukada K
    Cell Growth Differ; 1992 Aug; 3(8):515-21. PubMed ID: 1356417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression.
    Bruel A; Benoit G; De Nay D; Brown S; Lanotte M
    Leukemia; 1995 Jul; 9(7):1173-84. PubMed ID: 7630193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of N-linked glycosylation induces early apoptosis in human promyelocytic HL-60 cells.
    Pérez-Sala D; Mollinedo F
    J Cell Physiol; 1995 Jun; 163(3):523-31. PubMed ID: 7775595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of retinoic acid (RA) and N-(4-hydroxyphenyl) retinamide (4-HPR) on cell growth, induction of differentiation, and changes in p34cdc2, Bcl-2, and actin expression in the human promyelocytic HL-60 leukemic cells.
    Dipietrantonio A; Hsieh TC; Wu JM
    Biochem Biophys Res Commun; 1996 Jul; 224(3):837-42. PubMed ID: 8713132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B; Dubrez L; Allouche M; Solary E
    Cancer Res; 1997 Feb; 57(4):686-95. PubMed ID: 9044846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.